New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Functional and Symptomatic Clinical Trial Endpoints: The HFC-ARC Scientific Expert Panel.
Functional and Symptomatic Clinical Trial Endpoints: The HFC-ARC Scientific Expert Panel. JACC. Heart failure Psotka, M. A., Abraham, W. T., Fiuzat, M., Filippatos, G., Lindenfeld, J., Ahmad, T., Felker, G. M., Jacob, R., Kitzman, D. W., Leifer, E. S., Lewis, E. F., Mentz, R. J., Nkulikiyinka, R., Ni, W., Schaber, D. E., Sharma, A., Solomon, S. D., Stockbridge, N., Teerlink, J. R., Unger, E. F., Whellan, D. J., Wittes, J., Anker, S. D., O'Connor, C. M. 2022; 10 (12): 889-901Abstract
The Heart Failure Academic Research Consortium is a partnership between the Heart Failure Collaboratory (HFC) and the Academic Research Consortium (ARC) composed of patients, academic investigators from the United States and Europe, the U.S. Food and Drug Administration, the National Institutes of Health, payers, and industry. Members discussed the measure, remote capture, and clinical utility of functional and quality-of-life endpoints for use in clinical trials of heart failure and cardiovascular therapeutics, with the goal of improving the efficiency of heart failure and cardiovascular clinical research, evidence generation, and thereby patient quality of life, functional status, and survival. Assessments of patient-reported outcomes and maximal and submaximal exercise tolerance are standardized and validated, but actigraphy remains inconsistent as a potential endpoint. This paper details those discussions and consensus recommendations.
View details for DOI 10.1016/j.jchf.2022.09.012
View details for PubMedID 36456063